Systems thinking for assistive technology: a commentary on the GREAT summit

Disability and Rehabilitation. Assistive Technology
Malcolm MacLachlan, Marcia J Scherer

Abstract

The area of assistive technology has a long history of technological ingenuity and innovation. In order to ensure that the benefits of assistive technology are equitably distributed across the population and life course, it is necessary to adopt a systemic approach to the area. We describe examples of systems thinking and non-systems thinking across 10 Ps. These Ps are People (or users, as the primary beneficiaries of assistive technology), Policy, Products, Personnel, Provision (as key strategic drivers at systems level); and Procurement, Place, Pace, Promotion and Partnership (as key situational factors for systems). Together these Ps should constitute a framework for an "open" system that can evolve and adapt, that empowers users, inter-connects key components and locates these in the reality of differing contexts. The adoption of a stronger systems thinking perspective within the assistive technology field should allow for more equitable, more resilient and more sustainable assistive technology across high, middle- and low-income contexts and countries. Implications for Rehabilitation The progress of assistive technology provison has been hampered by disconnected initiatives and activities and this needs to be corrected. Sy...Continue Reading

References

Sep 8, 2005·Journal of Intellectual Disabilities : JOID·Karen Mellor, Dave Dagnan
Feb 2, 2006·American Journal of Public Health·John D Sterman
Feb 2, 2006·American Journal of Public Health·William M TrochimScott J Leischow
Dec 19, 2013·Implementation Science : IS·Ross BailieGill Schierhout
Dec 19, 2015·Lancet·Chapal KhasnabisMalcolm MacLachlan
Dec 3, 2016·Globalization and Health·Emma TebbuttRobert Horvath
May 19, 2018·Disability and Rehabilitation. Assistive Technology·Emma M SmithSam Wu
May 19, 2018·Disability and Rehabilitation. Assistive Technology·Deirdre DesmondMarcia J Scherer
May 24, 2018·Disability and Rehabilitation. Assistive Technology·Malcolm MacLachlanHilary Hooks

❮ Previous
Next ❯

Citations

May 24, 2018·Disability and Rehabilitation. Assistive Technology·Malcolm MacLachlanHilary Hooks
Mar 2, 2019·Disability and Rehabilitation. Assistive Technology·Rosemary Joan GowranJon Pearlman
Mar 25, 2020·Disability and Rehabilitation. Assistive Technology·Anna BerardiWilliam C Miller
Apr 3, 2020·Disability and Rehabilitation. Assistive Technology·Satish MishraManfred Huber
Apr 17, 2020·Disability and Rehabilitation. Assistive Technology·Natasha LaytonLuc de Witte
Jun 17, 2020·Journal of Medical Internet Research·Katarina BaudinSusanne Frennert
Nov 11, 2019·Disability and Rehabilitation. Assistive Technology·Åse BrandtJeanette Reffstrup Christensen
Aug 17, 2019·Disability and Rehabilitation. Assistive Technology·Abigail Bridey DavisNatasha Layton
Nov 28, 2018·International Journal of Environmental Research and Public Health·Malcolm MacLachlanDena Javadi
May 16, 2020·Occupational Therapy International·María L Toro-HernándezMary Goldberg
Dec 5, 2020·Disability and Rehabilitation. Assistive Technology·Moran RanMarcia J Scherer
Dec 11, 2020·Disability and Rehabilitation. Assistive Technology·Emma M SmithAlister Munthali
Feb 13, 2021·Disability and Rehabilitation. Assistive Technology·Katriona O'SullivanMalcolm Maclachlan
Apr 4, 2021·International Journal of Environmental Research and Public Health·Jun SuzurikawaTomoko Kondo
Apr 4, 2021·International Journal of Environmental Research and Public Health·Monica Jamali-PhiriAlister Munthali
May 1, 2021·International Journal of Environmental Research and Public Health·Qhayiya MagaqaSarah Polack
Nov 24, 2021·Disability and Rehabilitation. Assistive Technology·Diane BellNatasha Layton
Dec 25, 2021·Assistive Technology : the Official Journal of RESNA·Catherine HollowaySrinivasan Sujatha
Dec 25, 2021·Assistive Technology : the Official Journal of RESNA·Golnaz WhittakerKirstin Lange

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.